Original Article

You have full text access to this OnlineOpen article

Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis

  1. Kazuo Tarao M.D.1,†,*,
  2. Yasushi Rino M.D.2,
  3. Shinichi Ohkawa M.D.1,
  4. Setsuo Tamai M.D.1,
  5. Kaoru Miyakawa M.D.1,
  6. Hideki Takakura M.D.2,
  7. Osamu Endo M.D.3,
  8. Michiyasu Yoshitsugu M.D.4,
  9. Norihito Watanabe M.D.5,
  10. Shohei Matsuzaki M.D.5

Article first published online: 15 MAR 2002

DOI: 10.1002/cncr.10391

Issue

Cancer

Cancer

Volume 94, Issue 6, pages 1787–1795, 15 March 2002

Additional Information

How to Cite

Tarao, K., Rino, Y., Ohkawa, S., Tamai, S., Miyakawa, K., Takakura, H., Endo, O., Yoshitsugu, M., Watanabe, N. and Matsuzaki, S. (2002), Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis. Cancer, 94: 1787–1795. doi: 10.1002/cncr.10391

Author Information

  1. 1

    Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan

  2. 2

    Yokohama City University, School of Medicine, Yokohama, Japan

  3. 3

    Kanagawa Prefectural College of Nursing and Medical Technology, Yokohama, Japan

  4. 4

    Japanese Red Cross Medical Center, Tokyo, Japan

  5. 5

    Medical Department of Gastroenterology 1, Tokai University, Isehara, Japan

  1. †

    Fax: +81-45-361-4692

*Department of Gastroenterology, Kanagawa Cancer Center Hospital, 1-1-2, Nakao, Asahi-ku, Yokohama, 241-0815, Japan

  1. †

    Fax: +81-45-361-4692

Publication History

  1. Issue published online: 15 MAR 2002
  2. Article first published online: 15 MAR 2002
  3. Manuscript Accepted: 29 OCT 2001
  4. Manuscript Revised: 23 OCT 2001
  5. Manuscript Received: 8 MAR 2001

Funded by

  • Fund for Cancer Research from the Ministry of Welfare of Japan
  • Mitsui Life Social Welfare Foundation
  • Japanese Foundation for Multidisciplinary Treatment of Cancer
  • Viral Hepatitis Research Foundation of Japan

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (90K)

REFERENCES

  • 1
    Miyagawa S, Kawasaki S, Makuuchi M. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C. Hepatology. 1996; 24: 307–310.
    Direct Link:
  • 2
    Kubo S, Nishiguchi S, Hirohashi K, et al. Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis. Jpn J Cancer Res. 1999; 89: 419–426.
  • 3
    Ishikawa T, Takayama S, Kitagawa T. Correlation between time of partial hepatectomy after a single treatment with diethylnitrosamine and induction of adenosinetriphosphatase-deficient islands in rat liver. Cancer Res. 1980; 40: 4261–4264.
  • 4
    Tarao K, Hoshino H, Shimizu A, et al. Role of increased DNA synthesis activity of hepatocytes in multicentric hepatocarcinogenesis in residual liver of hepatectomized cirrhotic patients with hepatocellular carcinoma. Jpn J Cancer Res. 1994; 85: 1040–1044.
  • 5
    Tarao K, Ohkawa S, Shimizu A, et al. Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients. Cancer. 1994; 73: 1149–1154.
    Direct Link:
  • 6
    Tarao K, Rino Y, Ohkawa S, et al. Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer. 1999; 86: 589–595.
    Direct Link:
  • 7
    Zelman S, Wang CC. Transaminases in serum and liver correlated with liver cell necrosis in needle aspiration biopsies. Am J Med Sci. 1959; 237: 323–334.
  • 8
    Schmidt E, Schmidt FW, Wildhirt E. Activitäts-Bestimmungen von enzymen des energieliefernden stoffwechsels in menschlichen serum und in leberpunktaten bei leberkrankungen. Klin Wschr. 1958; 36: 280–287.
  • 9
    Baier H, Hennemann G, Mühler E. Beitrag zur aktivitätsbeurteilung chronischer Leberekrankungen druch bestimmung von serumenzymen. Klin Wschr. 1961; 39: 117–119.
  • 10
    Gratzner HG. Monoclonal antibody to 5-bromo- and 5-iodo-deoxyuridine: a new reagent for detection of DNA replication. Science. 1982; 218: 474–476.
  • 11
    Tarao K, Shimizu A, Ohkawa S, Tamai S. Prediction of the development of hepatocellular carcinoma from HCV associated liver cirrhosis. J Jpn Soc Intern Med. 1995; 84: 1985–1991.
  • 12
    Child CG III, Turcotte JG. Surgery and portal hypertension. In: DunphyJE, editor. The liver and portal hypertension. Philadelphia: WB Saunders, 1964: 50.
  • 13
    Yumoto Y, Jinno K, Tokuyama K. Hepatocellular carcinoma detected by iodized oil. Radiology. 1985; 154: 10–24.
  • 14
    Tanaka K, Sakai H, Hashizume M, Hirohata T. A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis. Jpn J Cancer Res. 1998; 89: 1241–1250.
  • 15
    Yoshida H, Shiratori Y, Moriyama M, et al. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med. 1999; 131: 174–181.
  • 16
    Kubo S, Yamamoto T, Ikebe T, et al. Relationship between multicentric occurrence of hepatocellular carcinoma and histology of non cancerous hepatic tissue in patients with chronic hepatitis C. Jpn J Cancer Res. 1999; 90: 1076–1080.
  • 17
    Okuda K, Tanaka M, Nakayama T, et al. Clinico-pathologic comparison between resected hepatocellular carcinoma (HCC) and recurrent tumors. Int Hepatol Commun. 1993; 1: 65–71.
  • 18
    Kajiwara M. MR imaging of small hepatocellular carcinoma (< or = 20 mm) correlation with vascularity and histological features. Kurume Med J. 1997; 44: 327–338.
  • 19
    Kenmochi K, Sugihara S, Kojiro M. Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC. Liver. 1987; 7: 18–26.
  • 20
    Kim SR, Kang KB, Soh CG, et al. Clinicopathological study of minimum-sized hepatocellular carcinoma: an approach to the definition of early hepatocellular carcinoma. J Gastroenterol Hepatol 1995; 10: 498–508.
    Direct Link:
  • 21
    Ohishi H, Uchida H, Yoshimura H, et al. Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology. 1985;154: 25–29.
  • 22
    Choi BI, Park JH, Kim BH, Kim SH, Han MC, Kim CW. Small hepatocellular carcinoma: detection with sonography, computed tomography (CT), angiography and lipiodol-CT. Br J Radiol. 1989; 62: 897–903.
  • 23
    Ngan H. Lipiodol computerized tomography: how sensitive and specific is the technique in the diagnosis of hepatocellular carcinoma? Br J Radiol. 1990; 63: 771–775.
View Full Article (HTML) Get PDF (90K)